New program aims to boost HIV medication adherence in black women

NCT ID NCT06463886

Recruiting now Disease control Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a 10-session counseling program called STEP-AD for Black women living with HIV who have a history of trauma. The goal is to help them stick to their HIV medication and achieve viral suppression. Researchers will enroll 250 participants and compare the program to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: counseling program (STEP-AD)
What this could lead to: If successful, this program could help Black women with HIV better manage their health by improving medication adherence and viral suppression.
What could go wrong: This is a behavioral intervention, not a drug, so results depend on participation and may not work for everyone. The trial is relatively small (250 participants) and early-stage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease injury Medication Adherence Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV MENTAL HEALTH ISSUE

Contacts and locations

Locations

University of Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.